Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 71335-2018

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 71335-2018). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Esomeprazolemagnesiumfigure1 (Esomeprazolemagnesiumfigure1)

Chemical structure of esomeprazole magnesium, showing the molecular configuration including a magnesium ion complexed with 3 water molecules (Mg2+·3H2O). The structure depicts two esomeprazole molecules coordinated with the magnesium ion.*

FDA Label Image

Esmoprazolemagnesiumfigure2 (Esomeprazolemagnesiumfigure2)

A line graph showing percent maintenance over six months for Esomeprazole Magnesium delayed-release capsules at 40 mg, 20 mg, and 10 mg doses compared to placebo. The x-axis represents months, and the y-axis represents percent maintained, with results indicating higher maintenance rates at higher doses over time.*

FDA Label Image

Esmoprazolemagnesiumfigure3 (Esomeprazolemagnesiumfigure3)

A line graph plotting percent maintained efficacy over months for Esomeprazole Magnesium delayed-release capsules at strengths of 10 mg, 20 mg, and 40 mg compared to placebo. The x-axis shows months from 0 to 6, and the y-axis shows percent maintained from 0 to 100%, with different line styles and markers for each group.*

FDA Label Image

Esomeprazolemagnesiumfigure4 (Esomeprazolemagnesiumfigure4)

A line graph depicting the percentage of patients symptom-free over 28 days for three groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and a placebo. The x-axis represents diary days from 0 to 28, and the y-axis shows the percent symptom-free ranging from 0 to 100. Both dosages of Esomeprazole show higher symptom-free percentages than the placebo throughout the period.*

FDA Label Image

Esomeprazolemagnesiumfigure5 (Esomeprazolemagnesiumfigure5)

A line graph showing the percent of patients symptom-free over 28 diary days, comparing three groups: Esomeprazole Magnesium Delayed-Release Capsules 20 mg, Esomeprazole Magnesium Delayed-Release Capsules 20 mg (duplicate or second data set), and Placebo. The y-axis represents the percent of patients symptom-free, ranging from 0 to 100%, while the x-axis shows diary days from 0 to 28. Both Esomeprazole groups show an increasing trend in symptom-free patients over time, higher than the placebo group's trend.*

FDA Label Image

Camber (Camber)

FDA Label Image

Label (Lbl713352018)

Label for Esomeprazole Magnesium delayed-release capsules, 20 mg strength. The label shows a package of 30 capsules with a comparison to Nexium 20 mg capsules. It is labeled for prescription use only, supplied by Bryant Ranch Prepack with storage instructions at room temperature (20°-25°C). The package is identified by NDC 71335-2018-1 and includes a barcode and lot number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.